AMREX Fees and Costs — American Growth Cannabis Fund, Class E

Data updated: 2022-12-29

The net expense ratio is 6.02% (6.31% before fee waivers). This share class carries a maximum front-end sales load of 5.75% and a deferred sales charge of up to 1.00%. Portfolio turnover was 461%.

AMREX Fees and Expenses

Annual operating expenses and sales charges of AMREX. Prospectus, as of November 30, 2021.

Annual operating expenses
Management fee1.00%
12b-1 fee0.30%
Other expenses4.98%
Gross expense ratio6.31%
Fee waiver−0.29%
Net expense ratio6.02%
Sales charges
Max front load5.75%
Max deferred load1.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

AMREX Costs Over Time

On $10,000 invested in AMREX, assuming 5% a year before costs, total costs come to $3,944 over 5 years, cutting the return by 7.48% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Sales charges$668$575$575
Fund expenses (net expense ratio 6.02%)$596$1,764$2,901
Lost growth on money paid in costs$29$181$468
Total costs$1,293$2,520$3,944
Value after costs$9,207$9,056$8,819
Impact on return, per year12.93%8.25%7.48%

AMREX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2022.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 461%
  • Securities lending: none during the year

AMREX Agency Brokers

Commissions paid.

BrokerAmountShare

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.